On March 17, 2023, Robert Ruffolo resigned as a director of Aridis Pharmaceuticals, Inc. (the Company). Following more than six years of service to the Company, Dr. Ruffolo is retiring for personal family reasons and from being a director on other boards that he served on.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0571 USD | -3.22% | -3.38% | -18.54% |
1st Jan change | Capi. | |
---|---|---|
-18.54% | 2.83M | |
+16.27% | 121B | |
+12.75% | 107B | |
-2.10% | 24.82B | |
+0.99% | 22.48B | |
-9.47% | 18.32B | |
-42.28% | 16.33B | |
-17.39% | 15.31B | |
+5.49% | 14.08B | |
+28.07% | 11.74B |
- Stock Market
- Equities
- ARDS Stock
- News Aridis Pharmaceuticals, Inc.
- Aridis Pharmaceuticals, Inc. Announces the Resignation of Robert Ruffolo as Director